HFA Premium Access

Two year follow-up results from AUGMENT-HF: a multicenter randomized controlled clinical trial of the efficacy of left ventricular augmentation with algisyl in the treatment of heart failure.

Congress Presentation

About the speaker

Professor Andrew Stewart Coats

Heart Research Institute, Sydney (Australia)
111 presentations

9 more presentations in this session

The subset of patients with acute heart failure able to secrete relaxin-2 at pregnancy concentrations could have a longer survival.

Speaker: Doctor O. Miro (Barcelona, ES)


Discussion: RELAXIN-2.


The HeartLogic multi-sensor algorithm as an automatic predictor of heart failure events: results from the MultiSENSE Trial.

Speaker: Professor R. Gardner (Clydebank, GB)


Discussion: MultiSENSE.


Cardiopoietic stem cell therapy improved left ventricular remodeling: longitudinal results from the CHART-1 study.

Speaker: Professor J. Teerlink (San Francisco, US)


Access the full session

Late Breaking Trials III: Innovative and device therapies

Speakers: Professor A. Stewart Coats, Doctor O. Miro, Professor R. Gardner, Professor J. Teerlink

About the event


Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb